PepsiCo (NASDAQ:PEP) said on Tuesday (October 2) that it will evaluate the cannabis industry in the wake of beverage companies gaining entries into the booming space.
Hugh Johnston, chief financial officer (CFO) of the beverage company, said no deal is currently in place but plans to study the sector during a televised interview.
“I think we’ll look at it critically, but I’m not prepared to share any plans that we may have in the space right now,” he said.
PepsiCo would join its beverage counterpart, The Coca-Cola Company (NYSE:KO), in showing interest for a cannabis play. A report from BNN Bloomberg showed alcohol producer Diageo (NYSE:DEO) was also eyeing a partnership in the cannabis space.
“Along with many others in the beverage industry, we are closely watching the growth of non-psychoactive CBD as an ingredient in functional wellness beverages around the world. The space is evolving quickly. No decisions have been made at this time,” Coca-Cola said at the height of a report indicating it would partner with Aurora Cannabis (TSX:ACB) in some form.
Other beverage companies have already gained direct exposure through partnerships with cannabis producers. Last November alcohol producer Constellation Brands (NYSE:STZ) formed an investment partnership with Canopy Growth (NYSE:CGC,TSX:WEED).
This relationship was renewed in August when Constellation made a second investment worth C$5 billion in Canopy’s business.
“Over the past year, we’ve come to better understand the cannabis market, the tremendous growth opportunity it presents, and Canopy’s market-leading capabilities in this space,” Rob Sands, CEO of Constellation Brands, said in a press release.
At the core of these relationships is the intention to bring forward a new type of product into the legal market: infused cannabis beverages. The bet these companies are making is for a drink that can offer a buzz to consumers with no calories.
Infused beverages haven’t caught the eye of just major producers; many small-to-mid cap cannabis companies have also announced intentions to develop some form of cannabis-infused beverage.
These beverages have been available to consumers in refined cannabis black markets like Colorado and California, but one thing companies are working on as validation is the refinement behind these new drinks.
“Some people are impatient looking for that effect so they drink too much and when it finally hits, they are out of it for a long, long time, Kris Dahl, VP of corporate development with Sproutly (CSE:SPR) told the Investing News Network (INN).
“Ours are less than five minutes onset and in less than 90 minutes it’s fully out of your system,” Dahl explained.
Despite recreational legalization of cannabis arriving in Canada on October 17, infused beverages won’t become immediately available to legal consumers.
Health Canada, the government agency tasked with regulating the drug, has indicated legalization for infused products and cannabis edibles will be arriving approximately a year after legalization.
The confirmation from PepsiCo’s potential interest in cannabis adds another major player into the mix for a possible entry. This move has brought legitimacy to the cannabis play and a wider set of investors to take notice.
Don’t forget to follow us @INN_Cannabis for real-time updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).